文献速递泌尿系感染小儿泌尿与泌尿修复

长期低剂量抗生素预防对儿童肠道菌群的影响

Impact of Long-Term Low Dose Antibiotic Prophylaxis on Gut Microbiota in Children.
PubMed 文献 · J Urol · 2020-07-02

本研究对35例3岁以下发热性尿路感染患儿进行16S rRNA基因测序,比较接受与未接受甲氧苄啶-磺胺甲噁唑预防的患儿肠道菌群变化。结果显示预防组肠道菌群多样性维持正常,且肠杆菌目比例显著降低(p=0.002)。

要点

  • 长期低剂量TMP-SMX预防不显著影响肠道菌群多样性(p=0.43)。
  • 预防组肠道菌群中肠杆菌目比例显著降低(p=0.002)。
  • 预防可能选择性抑制大肠埃希菌和克雷伯菌等发热性尿路感染主要致病菌。

核心结论

  • 长期低剂量TMP-SMX预防对儿童肠道菌群多样性影响不显著,但可选择性抑制肠杆菌目生长。

研究设计与样本

  • 前瞻性队列研究,纳入35例3岁以下发热性尿路感染患儿,其中23例接受TMP-SMX持续预防,12例未接受预防。
  • 采用16S rRNA基因测序分析粪便样本,采样时间点为发热性尿路感染发病及抗生素治疗前、治疗期间及治疗后1-2、3-4、5-6个月。

主要发现

  • 治疗开始后2周内几乎全部肠道细菌属于乳杆菌目,菌群多样性从治疗前平均Shannon指数2.9降至治疗期间1.4。
  • 两组患儿菌群多样性均在发病后1-2个月内恢复,研究期间两组多样性维持稳定(p=0.43)。
  • 预防组肠道菌群中肠杆菌目所占比例显著低于非预防组(p=0.002)。

临床怎么用

  • 对于需长期低剂量TMP-SMX预防的患儿,可预期肠道菌群多样性不受显著影响,但肠杆菌目细菌受抑制可能降低尿路感染风险。

局限性

  • 样本量较小(35例),且仅针对3岁以下儿童,结论外推需谨慎。
  • 未报告预防组与非预防组基线特征的详细比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated the effect of long-term low dose antibiotic prophylaxis on children's gut microbiota. MATERIALS AND METHODS: We conducted 16S ribosomal RNA gene sequencing using stool samples from 35 patients younger than 3 years old (median age 5.2 months; male-to-female ratio 17:18) who underwent antibiotic treatment during the acute phase of febrile urinary tract infection. Samples were collected at 5 time points, ie before, during and at 1 to 2, 3 to 4, and 5 to 6 months after febrile urinary tract infection onset and antibiotic treatment. Continuous antibiotic prophylaxis using trimethoprim-sulfamethoxazole was initiated in 23 patients with grade III or higher vesicoureteral reflux and was not administered in 12 patients without reflux. RESULTS: Within 2 weeks after initiation of treatment for febrile urinary tract infection almost all enteric bacteria belonged to the order Lactobacillales, and gut microbiota diversity decreased compared to the pretreatment level (average Shannon index 2.9 before treatment, 1.4 during treatment). The diversity recovered within 1 to 2 months after febrile urinary tract infection onset in both groups. Diversity was maintained during the study period in both groups (p=0.43). A smaller proportion of gut microbiota component belonged to the order Enterobacteriales (p=0.002) in the antibiotic prophylaxis group. CONCLUSIONS: Our results revealed that patients receiving continuous antibiotic prophylaxis had normal gut microbiota diversity, indicating that the effect of trimethoprim-sulfamethoxazole on gut microbiota was insignificant. Furthermore, prophylaxis with trimethoprim-sulfamethoxazole might selectively suppress the growth of bacteria belonging to the order Enterobacteriales, such as Escherichia coli and Klebsiella species, which are the main causative bacteria of febrile urinary tract infections.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Akagawa Y, Kimata T, Akagawa S, et al. Impact of Long-Term Low Dose Antibiotic Prophylaxis on Gut Microbiota in Children. J Urol. 2020. PMID: 32614253. doi:10.1097/JU.0000000000001227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。